Relates to medical assistance for patients for infertility treatment

This bill would require New York's Medicaid program to cover ovulation-enhancing drugs and specific monitoring services for women seeking infertility treatment. It mandates coverage for the drugs themselves, office visits, hysterosalpingograms, pelvic ultrasounds, and blood tests necessary to monitor the treatment. If federal funding for these services falls below 90%, the state must use its own funds to create a grant program to maintain coverage. The bill directly affects Medicaid-eligible women undergoing infertility treatment by expanding their covered services to include these specific treatments and monitoring procedures.